MPN-MDS EU Focus 2024

We are excited to share the video course from the 6th Annual MPN-MDS EU Focus 2024, originally held at the SANA Malhoa Hotel in Lisbon, Portugal, on August 30-31, 2024.

Enroll for free

Course curriculum

1. Dr. Tiziano Barbui - Chip and Thrombosis - Where is the link
2. Dr. Maria Teresa Voso - Chip and MDS
3. Dr. Mrinal S. Patnaik - MDS and CCUS Classifications
4. Session 1 Panel Discussion
1. Dr. Ruben Mesa - New Therapies in ET & PV
2. Dr. Heinz Gisslinger - Is Leukocytosis Important in PV
3. Dr. Rajko Kušec - Is Leukocytosis Important in PV
4. Dr. Jean-Jacques Kiladjian - How Real-world Data Inform the Treatment of PV
5. Dr. Steffen Koschmieder - How Real-world Data Inform the Treatment of PV
6. Session 2 - Debate
1. Dr. Martin Griesshammer - How I Manage Essential Thrombocythemia in 2024 - Facts and Fictions
2. Dr. Mary Frances McMullin - Diagnosis and Management of Non-JAK2 Mutated Erythrocytosis
3. Dr. Ivana Urošević - MPN in the Younger
4. Session 3 - Panel Discussion
1. Dr. Haifa Kathrin Al-Ali - How I Treat Low-Intermediate Risk MF in 2024
2. Dr. Massimo Breccia - Cytopenic MF at the Frontiers of New Therapies
3. Dr. Alessandro M. Vannucchi - Are we Ready for Combination Therapies in MF
4. Session 4 - Panel Discussion
1. Dr. Deepti Radia - Novel Perspectives for the Treatment of Systemic Mastocytosis
2. Dr. Andreas Reiter - Clonal Eosinophilic Neoplasms - Diagnosis and Therapeutic Options
3. Dr. Carmelo Gurnari - Vexas Syndrome
4. Dr. Elias Jabbour - How do I Manage CML in 2024
5. Session 5 Panel Discussion
1. Dr. Eric Solary - CMML Management in 2024
2. Dr. Rami Komrokji - MDS-MPN-RS-T
3. Dr. Mrinal S. Patnaik - MDS-MPN with Neutrophilia
4. Session 6 - Panel Discussion
1. Dr. Matteo Della Porta - The Spectrum and Heterogeneity of Ineffective Haematopoiesis in MDS
2. Dr. Valeria Santini - How do I Risk Stratify MDS
3. Dr. Uwe Platzbecker - TGF-B Inhibitors for Lower Risk MDS
4. Dr. Michael R. Savona - Role of Telomerase Inhibition in MDS Management
5. Session 7 - Panel Discussion
1. Dr. María Julia Montoro Gómez - State of the Art Managing del 5 q in MDS
2. Dr. Thomas Cluzeau - What is New in Higher Risk MDS
3. Dr. Anne Sophie Kubasch - Innovations in Digital Health- Transforming the Management of Myelodysplastic Syndromes with New Digital Tools
4. Session 8 - Panel Discussion
1. Dr. Nicolaus Kröger - Updated Recommendations for HSCT in MF
2. Dr. Francesco Mannelli - Management of BP-MPN
3. Dr. Astrid Marta Olsnes - Role of MRD Assessment in MDS
4. Dr. Paola Guglielmelli - Should we Aim for Molecular Remission in MPN
5. Dr. Uwe Platzbecker - HSCT for MDS - Do we Need Treatment Before and After - Yes -
6. Dr. Nicolaus Kröger - HSCT for MDS - Do we Need Treatment Before and After - No
7. Session 9 - Panel Discussion

About this course

Free
43 lessons
12 hours of video content

MPN-MDS EU Focus 2024

Course curriculum

Session I: Mutations and Classification of MPN and MDS

Session II: Polycythemia Vera (PV)

Session III: Essential Thrombocytopenia (ET) and Special Situations

Session IV: Myelofibrosis

Session V: Other MPNs & Co

Session VI: MDS/MPN Overlap Syndromes

Session VII: Myelodysplastic Syndromes (MDS)

Session VIII: Hematopoietic Stem Cell Transplantation (HSCT) & MRD Assessment

Session IX: Hematopoietic Stem Cell Transplantation (HSCT) & MRD Assessment

About this course

Video